NC
ACOR

Nexthera Capital’s Acorda Therapeutics ACOR Stock Holding History

Nexthera Capital’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,290
Closed -$2.06M – 33
2019
Q1 		$2.06M Buy
+1,290
New +$2.32M 2.5% 16
2018
Q4 		– Sell
-417
Closed -$983K – 48
2018
Q3 		$983K Sell
417
-820
-66% -$2.54M 0.19% 49
2018
Q2 		$4.26M Buy
+1,237
New +$3.79M 0.66% 31

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Nexthera Capital's ACOR Position: Q2 2019 in Review

Nexthera Capital sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 1,290 shares — an estimated $2.06M sold.

Nexthera Capital first reported a position in ACOR in Q2 2018 and held it in 3 quarters. The position peaked at $4.26M in Q2 2018. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

  • Nexthera Capital reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Nexthera Capital sold 1,290 Acorda Therapeutics shares in Q2 2019, an estimated $2.06M.
  • Nexthera Capital first reported a position in Acorda Therapeutics in Q2 2018 and held it in 3 quarters.
  • Nexthera Capital's Acorda Therapeutics position peaked at $4.26M in Q2 2018.
  • 163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on Nexthera Capital's 13F filing for Q2 2019, filed 14 Aug 2019.